PLURISTEM THERAPEUTIC (PSTI) Covered Calls

Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.

You can sell covered calls on PLURISTEM THERAPEUTIC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PSTI (prices last updated Fri 2:50 PM ET):

PLURISTEM THERAPEUTIC (PSTI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.11 +0.01 1.09 1.11 204K - 0.1B
Covered Calls For PLURISTEM THERAPEUTIC (PSTI)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 1 0.10 1.01 -1.0% -10.1%
Mar 15 1 0.15 0.96 4.2% 12.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Pluristem Therapeutics, Inc. engages in the development of standardized cell therapy products for the treatment of life threatening diseases. Its patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory diseases. It offers to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The company was founded on May 11, 2001 and is headquartered in Haifa, Israel.